This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Jean Paoli & Irène Calmettes, National Institute of Health and Medical Research. Active years: 2024.
Company Filing History:
2 out of 5,383 
2 out of 32 
2 out of 1,853 
Years Active: 2024
Title: Aude De Gassart: Innovator in Cancer Treatment
Introduction
Aude De Gassart is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of medical research, particularly in the development of innovative treatments for cancer and infectious disorders. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Aude's latest patents include the development of anti-BTN3A antibodies. These humanized antibodies specifically bind to human BTN3A and are utilized in treating cancer and infectious disorders. This groundbreaking invention holds promise for improving patient outcomes in these challenging medical conditions.
Career Highlights
Throughout her career, Aude has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Institut Jean Paoli & Irène Calmette. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Aude has collaborated with notable professionals, including Alemseged Truneh and Daniel Olive. These partnerships have further enhanced her research and contributed to the advancement of her projects.
Conclusion
Aude De Gassart's innovative work in developing anti-BTN3A antibodies exemplifies her commitment to advancing medical science. Her contributions are vital in the ongoing fight against cancer and infectious diseases.